Evidence map›Paper›PMID 33111099›Full record

ArticleSTAR protocols2020

High-Throughput Mass Cytometry Staining for Immunophenotyping Clinical Samples.

Emily M Thrash, Katja Kleinsteuber, Emma S Hathaway, Matthew Nazzaro, Eric Haas, F Stephen Hodi, Mariano Severgnini

Registry-linked trialAbstract read
In one paragraph

Article in STAR protocols, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05414487 (Exploring the Effects of B Cell Depletion With Ofatumumab on Immune Cells and Meningeal Lymphatic Drainage in Patients With Demyelinating Diseases - a Prospective Observational Study), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05414487 unknown statusnot on this mapstarted 2022, after this paper: background citation

Exploring the Effects of B Cell Depletion With Ofatumumab on Immune Cells and Meningeal Lymphatic Drainage in Patients With Demyelinating Diseases - a Prospective Observational Study

TypeobservationalSponsorTianjin Medical University General HospitalRan2022 to 2024Enrolled34ConditionsMultiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, Demyelinating Diseases of the Central Nervous SystemArmsOfatumumab
3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Data processing workflow for large-scale immune monitoring studies by mass cytometry.Computational and structural biotechnology journal · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emily M ThrashCenter for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Katja KleinsteuberCenter for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Emma S HathawayCenter for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Matthew NazzaroCenter for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Eric HaasLongwood Medical Area CyTOF Core, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
F Stephen HodiCenter for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Mariano SevergniniCenter for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As mass cytometry (MC) is implemented in clinical settings, the need for robust, validated protocols that reduce batch effects between samples becomes increasingly important. Here, we present a streamlined MC workflow for high-throughput staining that generates reproducible data for up to 80 samples in a single experiment by combining reference sample spike-in and palladium-based mass-tag cell barcoding. Although labor intensive, this workflow decreases experimental variables and thus reduces technical error and mitigates batch effects.

Indexed as

AntibodiesFlow CytometryHigh-Throughput Screening AssaysHumansImmunophenotypingLeukocytes, MononuclearMass SpectrometryStaining and LabelingAntibodies

Identifiers

PMID33111099
PMCPMC7580234

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.